PrEP could prove to be an important opportunity in the field of HIV prevention, yet there are many ethical and practical concerns that need to be addressed as the research moves forward. Currently, there is limited dialogue around these issues and the impact that PrEP trial results will have in Canada and globally. It is important that Canadians develop an understanding of PrEP and related issues so that they are able to participate in a global dialogue and assess if or how PrEP could benefit Canadians. This fact sheet provides an overview of PrEP research and raises some of the concerns and unanswered questions that require discussion among a broad group of stakeholders.
Publication Categories
Archives(2)
Combination Prevention(26)
Community and Health Systems Strengthening(9)
HIV and Co-infections(4)
Key Populations and Vulnerable Groups(19)
Public Policy and Global Engagement(11)
Reproductive, Maternal, Newborn and Child Health (RMNCH)(1)
Social Determinants of Health(15)
Toolkits(7)
Twinning(6)
Publication
Pre-exposure Prophylaxis (PrEP) as a Potential HIV Prevention Method
Related Content:
Moving Forward from the Canadian Policy Dialogue on TB and HIV: Key Policy and Programming Considerations for the Canadian Response to TB and HIV August 20, 2019 This resource, by ICAD in partnership with Results Canada, is the result of multi-sectoral policy dialogue on TB and HIV which brought together participants from several sectors, working in many…
CHABAC Hubs to host Community Roundtables to coincide with World AIDS Day November 28, 2018 28 November 2018 - The Canadian HIV/AIDS Black, African and Caribbean (CHABAC) Network is hosting community roundtables in Ottawa, Edmonton, Toronto, Calgary and Halifax beginning December 1, 2018 to consult…
Closing the Gap? Cut the Crap! December 4, 2018 New Research Priorities from the US National Institutes of Health (NIH) Restricts Prevention OptionsBy Marc-André LeBlanc, Founding member of IRMA International Rectal Microbicide Advocates (IRMA) and our many partners and…- Statement: European Medicine’s Agency Positive Opinion on Dapivirine Ring is a Turning Point towards Women-centred HIV Prevention July 24, 2020 FOR IMMEDIATE RELEASE 24 July 2020 (Ottawa, ON) – ICAD congratulates the International Partnership on Microbicides (IPM) on its announcement today that the European Medicine’s Agency (EMA) has issued a…
Canadian TB and HIV Communities Come Together: Supporting collaboration across sectors for greater impact April 24, 2020 The Interagency Coalition on AIDS and Development (ICAD) and Results Canada are pleased to jointly launch two new resources focusing on the collaborative TB and HIV response. The resources, ‘Moving…- Bridging the Gap Between Community and Researchers December 4, 2018 By Jes Hovanes, Communications and Social Media Officer, CIHR Canadian HIV Trials NetworkThere is a line in Tony Kushner’s 1991 play Angels in America where, in the early days of…